Cargando…
Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma
BACKGROUND AND OBJECTIVES: Investigations of the prognosis are vital for better patient management and decision-making in patients with advanced metastatic renal cell carcinoma (mRCC). The purpose of this study is to evaluate the capacity of emerging Artificial Intelligence (AI) technologies to pred...
Autores principales: | Barkan, Ella, Porta, Camillo, Rabinovici-Cohen, Simona, Tibollo, Valentina, Quaglini, Silvana, Rizzo, Mimma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978529/ https://www.ncbi.nlm.nih.gov/pubmed/36874081 http://dx.doi.org/10.3389/fonc.2023.1021684 |
Ejemplares similares
-
Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis
por: Rizzo, Mimma, et al.
Publicado: (2022) -
IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Rizzo, Mimma, et al.
Publicado: (2022) -
Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers
por: Rizzo, Mimma, et al.
Publicado: (2021) -
Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors
por: Pezzicoli, Gaetano, et al.
Publicado: (2021) -
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)